Analyzing Quest Diagnostics, Inc (DGX) After Recent Trading Activity

In a filing, Quest Diagnostics, Inc revealed its Officer Plewman Patrick acquired Company’s shares for reported $12960.0 on Aug 15 ’25. In the deal valued at $180.00 per share,72 shares were bought.

Then, Plewman Patrick bought 1,903 shares, generating $342,540 in total proceeds.

Before that, Plewman Patrick sold 5,535 shares. Quest Diagnostics, Inc shares valued at $968,625 were divested by the SVP for Diagnostic Services at a price of $175.00 per share. As a result of the transaction, Plewman Patrick now holds 19,219 shares, worth roughly $3.44 million.

Redburn Atlantic initiated its Quest Diagnostics, Inc [DGX] rating to a Buy in a research note published on April 02, 2025; the price target was $195. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Leerink Partners also remained covering DGX and has increased its forecast on January 06, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on December 17, 2024. It rated DGX as “an Overweight” which previously was an “an Equal-weight”.

Price Performance Review of DGX

On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -0.46% to $178.95. Over the last five days, the stock has gained 0.33%. Quest Diagnostics, Inc shares have risen nearly 19.42% since the year began. Nevertheless, the stocks have risen 18.62% over the past one year. While a 52-week high of $182.38 was reached on 06/16/25, a 52-week low of $146.17 was recorded on 01/16/25.

Levels Of Support And Resistance For DGX Stock

The 24-hour chart illustrates a support level at 178.38, which if violated will result in even more drops to 177.81. On the upside, there is a resistance level at 179.98. A further resistance level may holdings at 181.01.

How much short interest is there in Quest Diagnostics, Inc?

A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-07-31, dropping by -0.24 million shares to a total of 4.74 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 4.98 million shares. There was a decline of -5.08%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.